SBIR/STTR Research Award

Engineered Tissue Based Phenotypic Screening of Mixture based Libraries

Award identifier 0927b33608105ffce0d60eb6716350d598d39dd2cd3ee63f79b59a3775f3a596Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$758,660

Program and phase

SBIR · Phase I

Award year

2015

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
InvivoSciences, Inc.
Proposal award date
2015-09-30
Contract end date
2018-05-31
UEI
G5JDXMW3NSW3
Solicitation number
PA15-322
Topic code
NIA

Research abstract

DESCRIPTION provided by applicant We propose to demonstrate the strength of combining our engineered tissue based drug screening approach and a systematically organized mixture based chemical library This approach could become an ultimate tool to develop treatments for complex diseases such as cardiac fibrosis without known drug targets initially Heart failure is the most common cause of hospitalization among Americans or older The heart failure with preserved ejection fraction HFPEF is becoming an epidemic among increasing population of aging Americans Existence of activated fibroblasts i e myofibroblasts differentiated from fibroblasts endothelial cells and non muscle cell is a hallmark of myocardium with HFPEF and they stiffen myocardium to progress HFPEF We developed a disease model for the human cardiac fibrosis using myofibroblast containing engineered tissue constructs that recapitulate connective tissues of myocardium with fibrosis Using our phenotypic screening system we identified TPI compound mixture after analyzing a scaffold scaffold ranking library each scaffold sample contains mixtures of compounds which is equivalent to screening andgt million compounds While our final goal is to identify a novel drug for treating cardiac fibrosis the proposed Phase I project will focus on performing a secondary sample screening of a compound mixture in the chemical scaffolds and identifying individual compounds to pick hit compounds to be tested and optimized in Phase II study In a parallel study we will analyze mechanisms of action of TPI in fibrosis relieving phenotypes and identify potential drug targets by performing affinity free target identification method stabilizing target molecules with individual hit compounds Successful demonstration of combing engineered tissue based drug discovery system and scaffold ranking library with positional scanning technology will be extended to other drug discovery projects for age related dieses such as osteoarthritis PUBLIC HEALTH RELEVANCE Heart injuries such as heart attaches leave non healing wounds and develop stiff scars that hamper healthy pump function While almost all heart failure patients aged years develop this condition cardiac fibrosis no effective treatment exists Our novel drug screening system using human grown wound tissues screens a chemical library that is systematically designed to identify drug candidates running fewer tests

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

15 SBIR/STTR records share this UEI (2004–2022). Reported award amounts total $12,363,639. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.